Antidiabetic Agents|Journals Open Access|antidiabetic Agents

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Antidiabetic Agents

"Numerous researches have been carried out worldwide on molecular targets towards the development of newer antidiabetic agents like nuclear receptor PPAR-? (peroxisome proliferator-activated receptor gamma), human incretin-degrading enzyme DPP-IV (dipeptidylpeptidase IV), protein-tyrosine phosphatase 1B (PTP1B), etc. These therapeutic targets may improve the efficacy-to-safety ratio, resulting in durable maintenance of glycaemic control in the majorityof people with diabetes. Several structurally unrelated natural products, including alkaloids, flavonoids or organic acids had also been described to interact with these diabetic proteins in micromolar concentrations. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide. Citation: Bharti SK, Kumar A, Prakash O, Krishnan S, Gupta AK (2013) Essential Oil of Cymbopogon Citratus Against Diabetes: Validation by In vivo Experiments and Computational Studies. J Bioanal Biomed 5: 194-203."
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021